Substance use among adolescents and young adults with chronic kidney disease or kidney failure

Nianzhou Xiao; Hua Chai; Abiodun Omoloja

doi:10.1007/s00467-021-05001-2

Substance use among adolescents and young adults with chronic kidney disease or kidney failure

Pediatr Nephrol. 2021 Nov;36(11):3585-3593. doi: 10.1007/s00467-021-05001-2. Epub 2021 Mar 9.

Authors

Nianzhou Xiao¹, Hua Chai², Abiodun Omoloja^{3

4}

Affiliations

¹ Department of Nephrology, Valley Children's Healthcare, Madera, CA, USA.
² Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, CA, USA.
³ Department of Pediatrics, Wright State University, Dayton, OH, USA. Omolojaa@childrensdayton.org.
⁴ Division of Nephrology, Dayton Children's Hospital, One Children's Plaza, Dayton, OH, 45404, USA. Omolojaa@childrensdayton.org.

PMID: 33686466
DOI: 10.1007/s00467-021-05001-2

Abstract

Substance use, a significant public health issue, is well described in the adult chronic kidney disease (CKD) population. Knowledge about substance use in the adolescent and young adult (AYA) CKD population such as prevalence, impact on kidney function, medication adherence, and psychosocial well-being remain largely unknown. Awareness of and inquiring about substance use is paramount to providing evidence-based care and preparation to transition to adult-focused health services. The authors in this review identify commonly used substances (alcohol, tobacco, marijuana, etc.) and how they impact kidney function and care of the AYA with CKD or kidney failure. Recommendations for screening and intervention strategies are provided.

Keywords: Adolescents; Chronic kidney disease; Kidney failure; Substance use; Young adults.

Publication types

Review

MeSH terms

Adolescent
Humans
Renal Insufficiency* / epidemiology
Renal Insufficiency, Chronic* / epidemiology
Substance-Related Disorders* / epidemiology
Young Adult